Skip to main content

and
  1. Article

    Open Access

    Healthcare resource utilisation and associated costs after low-risk pulmonary embolism: pre-specified analysis of the Home Treatment of Pulmonary Embolism (HoT-PE) study

    Pulmonary embolism (PE) and its sequelae impact healthcare systems globally. Low-risk PE patients can be managed with early discharge strategies leading to cost savings, but post-discharge costs are undetermined.

    Ioannis T. Farmakis, Klaus Kaier, Lukas Hobohm in Clinical Research in Cardiology (2024)

  2. Article

    Open Access

    Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2

    Right ventricular (RV) function plays a critical role in the pathophysiology and acute prognosis of pulmonary embolism (PE). We analyzed the temporal changes of RV function in the cohort of a prospective multi...

    Anna C. Mavromanoli, Stefano Barco, Walter Ageno in Clinical Research in Cardiology (2023)

  3. Article

    Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis

    Data regarding the occurrence of venous thromboembolic events (VTE), including acute pulmonary embolism (PE) and deep vein thrombosis (DVT) in recovered COVID-19 patients are scant. We performed a systematic r...

    Marco Zuin, Stefano Barco, George Giannakoulas in Journal of Thrombosis and Thrombolysis (2023)

  4. No Access

    Article

    Risk stratification and risk-adapted management of acute pulmonary embolism

    Pulmonary embolism is one of the leading causes of cardiovascular death in Europe. Rapid diagnosis and treatment initiation are essential, especially in hemodynamically unstable patients. For normotensive pati...

    Dr. med. Natascha Kohls, Stavros V. Konstantinides in Wiener klinische Wochenschrift (2023)

  5. Article

    Open Access

    Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis

    Animal experiments and early phase human trials suggest that inhibition of factor XIa (FXIa) safely prevents venous thromboembolism (VTE), and specific murine models of sepsis have shown potential efficacy in ...

    Alejandro Pallares Robles, Vincent ten Cate, Andreas Schulz in Scientific Reports (2022)

  6. Article

    Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis

    Loris Roncon, Marco Zuin, Stefano Barco in Journal of Thrombosis and Thrombolysis (2021)

  7. Article

    Open Access

    Venous thromboembolism in patients hospitalized for knee joint replacement surgery

    Patients undergoing knee joint replacement (KJR) are at high risk of postoperative venous thromboembolism (VTE), but data on the time trends of VTE rate in this population are sparse. In this analysis of the G...

    Karsten Keller, Lukas Hobohm, Stefano Barco, Irene Schmidtmann in Scientific Reports (2020)

  8. Article

    Open Access

    Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism

    Recent studies demonstrate an improved prognostic performance of the 2014 European Society of Cardiology (ESC) algorithm for risk stratification of patients with pulmonary embolism (PE) compared to the 2008 ES...

    Lukas Hobohm, Cecilia Becattini in Clinical Research in Cardiology (2020)

  9. Article

    Open Access

    Temporal trends in management and outcome of pulmonary embolism: a single-centre experience

    Real-world data on the impact of advances in risk-adjusted management on the outcome of patients with pulmonary embolism (PE) are limited.

    Matthias Ebner, Karl-Patrik Kresoja, Karsten Keller in Clinical Research in Cardiology (2020)

  10. Article

    Open Access

    Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

    Symptoms and functional limitation are frequently reported by survivors of acute pulmonary embolism (PE). However, current guidelines provide no specific recommendations on which patients should be followed af...

    Stefano Barco, Mariaconcetta Russo, Eric Vicaut in Clinical Research in Cardiology (2019)

  11. No Access

    Article

    Pulmonary embolism

    Pulmonary embolism (PE) is caused by emboli, which have originated from venous thrombi, travelling to and occluding the arteries of the lung. PE is the most dangerous form of venous thromboembolism, and undiag...

    Menno V. Huisman, Stefano Barco, Suzanne C. Cannegieter in Nature Reviews Disease Primers (2018)

  12. Article

    Open Access

    Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study

    Acute pulmonary embolism (PE) is a frequent cause of death and serious disability. The risk of PE-associated mortality and morbidity extends far beyond the acute phase of the disease. In earlier follow-up stud...

    Stavros V. Konstantinides, Stefano Barco in Journal of Thrombosis and Thrombolysis (2016)

  13. No Access

    Article

    Expression of the leptin receptor in different types of vascular lesions

    Clinical and experimental evidence suggests that the adipokine leptin may be important for the development of cardiovascular complications associated with obesity, possibly through interaction with its recepto...

    Marco R. Schroeter, Jacob Schneiderman, Bettina Schumann in Histochemistry and Cell Biology (2007)